EBD ACADEMY PRE-EVENT COURSES
EBD Academy offers practical courses that are an ideal opportunity to boost your business development skills before attending BIO-Europe.
€200 Discount for BIO-Europe attendees
Access a €200 discount to any course if you are already registered for BIO-Europe 2025. Please reach out to Karis Ives kives@ebdgroup.com to receive the discount code.
Featured EBD Academy courses
Advanced Business Development
In-person, Vienna, Austria
October 31 – November 2, 2025
For business development professionals who want to bring their skills in valuation, deal structuring, due diligence, negotiation and contracts to the next level.
Biotech and Pharmaceutical Mini MBA
In-person, London, United Kingdom
November 24–28, 2025
This course is designed for biotech and pharmaceutical executives who want to enhance their commercial skills in strategic thinking, marketing, change management, business finance and managing commercial partnerships to take the business to new heights.
Negotiation
Online
June 2–6, 2025
For professionals who already have a business development role who want to gain experience with all parts of the negotiation process, learn the latest negotiation techniques and hone their skills for real-life dealmaking.
Fundamentals: Due Diligence
Online
October 6–16, 2025
This course is suitable for anyone likely to be involved in a due diligence evaluation and who would like to prepare for the process. Attendees may include executives and commercial managers and those in legal departments.
Pharmaceutical and Biotech Licensing
Online
September 15–October 16, 2025
This course is designed for those new to life science business development and licensing, someone who encounters licensing on a regular basis and would like to learn more, or someone considering a move into life science business development.
Product Valuation and Deal Structure
Online
September 23–30, 2025
Suitable for professionals who want to learn about valuation concepts, best practices for assessing and valuing assets and gain confidence in the financial aspect’s future negotiations.